Archive for In the News

SF Healthcare Week: insitro CEO Daphne Koller on how AI is hitting “escape velocity” for finding causal targets for disease and speeding up drug development

Read More

Bristol Myers, insitro extend research deal to find a drug for new ALS target

Read More

BIO 2025: As pharma deploys AI across the value chain, data remains a challenge

Read More

insitro makes headway on the harder road, discovering new ALS drug target

Read More

Better drugs through AI? insitro CEO on what machine learning can teach Big Pharma

Read More

On Nobel day for AI in drug discovery, Peninsula biotech, big drugmaker strike AI deal

Read More

AI biotech insitro partners with Lilly on metabolic disease drugs

Read More

Eli Lilly, insitro ink a new kind of AI drug development deal

Read More

insitro, biotech AI’s quiet unicorn, unveils efforts in ALS, liver disease, and cancer at JPM

Read More

insitro on Forbes AI 50 list

Read More

Next ›